Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
J Mater Sci Mater Med. 2013 Oct;24(10):2429-37. doi: 10.1007/s10856-013-4999-x. Epub 2013 Jul 12.
Articular cartilage defects are a significant source of pain, have limited ability to heal, and can lead to the development of osteoarthritis. However, a surgical solution is not available. To tackle this clinical problem, non-degradable implants capable of carrying mechanical load immediately after implantation and for the duration of implantation, while integrating with the host tissue, may be viable option. But integration between articular cartilage and non-degradable implants is not well studied. Our objective was to assess the in vivo performance of a novel macroporous, nondegradable, polyvinyl alcohol construct. We hypothesized that matrix generation within the implant would be enhanced with partial digestion of the edges of articular cartilage. Our hypothesis was tested by randomizing an osteochondral defect created in the trochlea of 14 New Zealand white rabbits to treatment with: (i) collagenase or (ii) saline, prior to insertion of the implant. At 1 and 3-month post-operatively, the gross morphology and histologic appearance of the implants and the surrounding tissue were assessed. At 3 months, the mechanical properties of the implant were also quantified. Overall, the hydrogel implants performed favorably; at all time-points and in all groups the implants remained well fixed, did not cause inflammation or synovitis, and did not cause extensive damage to the opposing articular cartilage. Regardless of treatment with saline or collagenase, at 1 month post-operatively implants from both groups had a contiguous interface with adjacent cartilage and were populated with chondrocyte-like cells. At 3 months fibrous encapsulation of all implants was evident, there was no difference between area of aggrecan staining in the collagenase versus saline groups, and implant modulus was similar in both groups; leading us to reject our hypothesis. In summary, a porous PVA osteochondral implant remained well fixed in a short term in vivo osteochondral defect model; however, matrix generation within the implant was not enhanced with partial digestion of adjacent articular cartilage.
关节软骨缺损是疼痛的主要来源,其自身愈合能力有限,并可能导致骨关节炎的发生。然而,目前尚无有效的手术解决方案。为了解决这一临床问题,能够在植入后立即承受机械负荷并在植入期间与宿主组织整合的不可降解植入物可能是一种可行的选择。但是关节软骨和不可降解植入物之间的整合情况尚未得到很好的研究。我们的目的是评估新型大孔、不可降解、聚乙烯醇构建体的体内性能。我们假设通过部分消化关节软骨的边缘,可增强植入物内的基质生成。我们通过将在 14 只新西兰白兔滑车的骨软骨缺损随机分为胶原酶或生理盐水处理组来检验我们的假设,然后将植入物插入其中。术后 1 个月和 3 个月时,评估植入物及其周围组织的大体形态和组织学表现。在 3 个月时,还定量评估了植入物的机械性能。总体而言,水凝胶植入物表现良好;在所有时间点和所有组中,植入物均保持良好固定,未引起炎症或滑膜炎,也未对相对的关节软骨造成广泛损伤。无论接受生理盐水还是胶原酶治疗,在术后 1 个月时,两组的植入物均与相邻软骨具有连续的界面,并充满类似软骨细胞的细胞。在术后 3 个月时,所有植入物均可见纤维包裹,胶原酶组与生理盐水组的聚集蛋白聚糖染色面积无差异,并且两组的植入物模量相似;这使我们否定了我们的假设。总之,在短期体内骨软骨缺损模型中,多孔 PVA 骨软骨植入物固定良好;然而,通过部分消化相邻关节软骨并不能增强植入物内的基质生成。